August 31, 2014

Should the FDA Have the Authority to Make Life and Death Decisions in Your Life?

pin it button Should the FDA Have the Authority to Make Life and Death Decisions in Your Life?


compassionate care Should the FDA Have the Authority to Make Life and Death Decisions in Your Life?

Health Impact News Editor Comments: While this story is disturbing, I think we should address the larger question as to whether the FDA should have the power and authority to force or stop anyone from making a personal decision about their health and the the products they choose to take, regardless of whether or not they are labeled “terminally ill.” If they want to approve or disapprove of certain drugs or foods, fine. But then just require a warning label that it is not approved, and let people make up their own minds. Just one look at the FDA “approved drugs”, that have been subsequently removed from the market because they were too dangerous and ended up harming people instead of helping them, should prove that the FDA should not have this kind of authority.

Should You Have to Fight FDA Red Tape to Save Your Life?

by Alliance for Natural Health

An upcoming congressional bill would give dying patients and physicians access to experimental drugs. Action Alert!

Imagine you’re terminally ill and have exhausted all the available treatment options. Your physician recommends a new, experimental treatment for your condition, but you’re ineligible to participate in ongoing clinical trials. You ask the drug company for treatment outside of their trials, but they say you have to go through the FDA first. Time’s running out, and you have to obtain permission to try to save your life—from the government! And you may never get permission.

This situation isn’t some Orwellian hypothetical situation: it’s a reality for thousands of dying patients. That’s why last year, former congressman Ron Paul introduced the Compassionate Freedom of Choice Act, which would have allowed terminally ill patients access to experimental drugs without FDA approval. Though the bill was left in the House, its supporters are not giving up. In fact, Representative Morgan Griffith of Virginia recently told us he will reintroduce the Act in Congress soon!

As we reported last May, the FDA does let terminally ill patients try experimental drugs and treatments under its “expanded access” rule. This allows the case-by-case use of an investigational new drug outside of a clinical trial if a patient has a serious or immediately life-threatening disease or condition and has no other treatment options left.

Unfortunately, the rule is woefully inadequate, marred by a prohibitively cumbersome application and documentation process. And remember, FDA can arbitrarily refuse access and even revoke permission once it’s granted! The application for expanded access requires a drug company to share information—which we all know drug companies don’t do very well. It also requires, among other things, a detailed description of how and where a drug will be produced; complex pharmacological and toxicological information; and, if enough patients ask for the drug, a whole new Investigational New Drug (IND) application by the drug company.

Furthermore, in what can only be described as a very bad joke, the FDA can deny expanded access if it deems the risks of an experimental drug too great for someone who is already terminally ill. Essentially, dying patients can be denied access to a drug because it could potentially make them sick. What the patient’s doctor thinks doesn’t matter.

Passing the Compassionate Care Act would erase all of these problems by removing the FDA middleman entirely from the equation, streamlining physician and patient access to experimental drugs. It would ensure that dying patients and their families—who don’t have the time or the strength to do so—won’t have to wage fruitless bureaucratic wars.

The heartbreaking story of Abigail Burroughs illustrates the need for the Act: shortly after turning twenty-one, Abigail ran out of conventional options in her battle against cancer. Abigail and her family turned their focus to obtaining one of two experimental cancer drugs that doctors felt had great promise of saving her life. Her efforts—thwarted by both the FDA and drug companies—were unsuccessful, and she died in 2001. Both drugs were eventually deemed safe by the FDA.

Under the Act, drug companies can still deny dying patients access to experimental treatments. But if they don’t have the FDA breathing down their necks, drug companies may be much more willing to say Yes. For example, drug companies are often afraid that if a patient dies under expanded access treatment, it will affect the eventual approval of the drug. Also, the FDA’s expanded access rule currently creates mountains of extra paperwork for drug companies and doctors. With less risk and less paperwork, drug companies are more likely to increase patient access to experimental drugs.

Detractors of this excellent bill may argue that FDA intervention is necessary to protect desperate patients from risky, untested drugs. However, full disclosure is a key component of the current draft of the Act, which states that in order to obtain an experimental drug, patients must first sign an informed consent document stating that they’re aware of the potential risks and benefits. Additionally, patients will need to work closely with their doctors (who will ultimately be the ones administering the experimental treatment), so it’s not as if they’re making important decisions without medical oversight.

They say only two things in life are certain: death and taxes. The government already mandates taxes; should they really mandate how terminally ill patients die, too?

Action Alert! Please write to your congressional representative and ask him or her to support and become a sponsor of this vital legislation. Also ask your senator to introduce similar legislation in the Senate. Please send your message today!

Take Action1 Should the FDA Have the Authority to Make Life and Death Decisions in Your Life?

Read the full article here:

Global Censorship of Health Information
The Politics of Controlling Therapeutic Information to Protect State-Sponsored Drug Monopolies

Global Censorship of Health Information book coversm Should the FDA Have the Authority to Make Life and Death Decisions in Your Life?

by Attorney Jonathan Emord
Free Shipping available!

0 commentsback to post

Other articlesgo to homepage

Study: Legalizing Medical Marijuana Leads to Fewer Prescription Drug Overdose Deaths

Study: Legalizing Medical Marijuana Leads to Fewer Prescription Drug Overdose Deaths

Pin It

A study published in the journal JAMA Internal Medicine on Monday found that states that had legalized medical marijuana had seen a 25 percent drop in deaths related to prescription drug overdoses.

According to ABC News, the researchers conducting the study found that because “legalizing medical marijuana makes it more available to chronic pain patients, it provides a potentially less lethal alternative to pain control on a long-term basis.”

Over the course of the study, the states studied were the ones that allowed access to medical marijuana. The Washington Post reported that those states “had 1,729 fewer overdose deaths in 2010 than would be predicted by trends in states without such laws.”

Dr. Marcus Bachhuber, a physician and researcher at the University of Pennsylvania, and the lead author of the study, told ABC News that while he did expect to see changes among the states that legalized medical marijuana, he found it “surprising that the difference is so big.”

Unapproved but Effective Cancer Cures

Unapproved but Effective Cancer Cures

Pin It

The conventional cancer treatment system and the pharmaceutical companies that control it are dedicated to limiting the development of all other forms of cancer treatment. They have a chokehold on the development of alternative treatments, and they ruthlessly work together with the US FDA and various US government cancer research funding agencies to prevent new treatments from being approved for use by physicians. The reason is that most alternative cancer treatments are much less expensive than surgery, radiation, and chemo. They are also more effective and have many fewer (if any) unwanted side effects.

The great fear of the pharmaceutical industry, and the vast cancer treatment system that it controls, is that a non-patentable and inexpensive cure for cancer might put them out of business. Sadly, these organizations exist to turn a profit from cancer treatment, which is measured in the billions of dollars every year. They are in the business of treating cancer not curing it.

Alternative treatments for cancer have a history of curing cancer and it is this fact that big pharma wants to hide from the American public. Historically, many successful approaches have been developed for curing cancer. We give a review of many of the most popular ones here.

Report: FDA Deliberately Deceptive – Poisoning Millions of Americans

Report: FDA Deliberately Deceptive – Poisoning Millions of Americans

Pin It

US consumers are in dark about mercury in dental products—and they are kept there deliberately by the government. This is documented in a new report being released this week by Consumers for Dental Choice called “Measurably Misleading: Evidence the FDA and Dental Industry are Deliberately Deceiving American Families about Mercury Dental Fillings and Why That Now Has International Consequences.”

Mercury is a known neurotoxin, yet mercury fillings presents one of the largest consumer consumption of mercury worldwide, and dental amalgam represents the largest use of mercury in consumer products in the US. We’ve also been kept in in the dark about mercury in other consumer products because of the FDA. Thimerosal, a mercury compound often found in flu vaccines, is being ignored as a danger.

Detox Your Liver with Homemade Lemon Water

Detox Your Liver with Homemade Lemon Water

Pin It

One of the drinks I routinely make for myself and my family in the mornings is lemon water. Not to be confused with “lemonade,” a sweetened beverage, lemon water is a detoxifying health drink consisting of nothing but one whole lemon and warm water.

Much of the research on lemon water’s ability to detoxify the liver is centered around the antioxidant D-Limonene, which is more concentrated in the peel of the lemon. D-limonene has been shown to activate enzymes in the liver that lead to detoxification. It has also been shown to treat cancer.

The Healing Properties of Clove Essential Oil

The Healing Properties of Clove Essential Oil

Pin It

The ancient texts all seem to agree on the many therapeutic properties of clove – it is a stimulant and has stomachic, expectorant, sedative, carminative, antispasmodic and digestive qualities. It helps flatulence, stimulates digestion and restores appetite, so is good for convalescence. It is a general tonic for both physical and intellectual weakness; and for those suffering from frigidity.

Its principal therapeutic value, though, is antiseptic because of the high proportion of eugenol. This is used for intestinal parasites, and for prevention of virus infections. It is good for the immune system, and particularly effective in mouth and tooth infections.

Here is a review of some of scientific studies published around the world regarding the healing properties of clove essential oil.

read more

Get the news right in your inbox!